Highlights
NASDAQ: ADVM       Adverum Biotechnlgs
Last Price Today's Change   Day's Range   Trading Volume
8.96   +0.13 (1.47%)  8.695 - 9.11  665,800

Overview

 
Avg Volume (4 weeks):787,375
4 Weeks Range:8.58 - 11.18
4 Weeks Price Volatility (%):
14.62%
52 Weeks Range:8.58 - 26.98
52 Weeks Price Volatility (%):
2.07%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Adverum Biotechnologies Inc is a US-based clinical-stage gene therapy company. The company is committed to discovering and developing novel medicines that can offer potentially life-changing therapeutic benefit to patients living with rare diseases or diseases of the eye, who currently have limited or burdensome treatment options. Its services are focused on advancing three lead gene therapy programs to address unmet needs in wet age-related macular degeneration and in rare diseases alpha-1 antitrypsin deficiency and hereditary angioedema. Its leading programs include ADVM-022, ADVM-043 and ADVM-053.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

3176  6453  678  102 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SNDL 0.94+0.12 
 CLOV 9.67+0.05 
 AMBO 2.45-0.07 
 CTRM 0.49+0.03 
 NAKD 0.556+0.053 
 AAPL 134.84+1.33 
 NIO 36.780.00 
 UVXY 4.74+0.19 
 VXX 10.17+0.28 
 ZOM 0.847+0.009